Company intelligence / Profile preview

RADLogics

New York City, New York, United Statesradlogics.com ↗

Ownership: Private
Employees: ~7
Development stage: Commercial

Overview

RADLogics’ AI-powered solutions are deployed worldwide to assist with rapid detection of lung abnormalities—including those compatible with COVID‑19—and cancer-associated findings. Their FDA-cleared applications have processed hundreds of thousands of cases and are integrated into clinical workflows to reduce diagnostic turnaround times from hours to minutes.

Therapeutic areas: PulmonologyOncologyOther
Modalities: Device
Industry: Medical Imaging

Partnerships

Nuance Communications

Beyond the preview

Go deeper on RADLogics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RADLogics.

Explore the full profile